A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ji-Young Lee |
| Publication date | January 16, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |